International Urogynecology Journal

, Volume 23, Supplement 1, pp 33–42 | Cite as

Informed surgical consent for a mesh/graft-augmented vaginal repair of pelvic organ prolapse

Consensus of the 2nd IUGA Grafts Roundtable: Optimizing Safety and Appropriateness of Graft Use in Transvaginal Pelvic Reconstructive Surgery
  • Dennis MillerEmail author
  • Alfredo L. Milani
  • Suzette E. Sutherland
  • Bonnie Navin
  • Rebecca G. Rogers
IUGA Grafts Roundtable 2010


Introduction and hypothesis

Complex issues surround informed surgical consent for pelvic reconstructive surgery.


Vaginally placed mesh/grafts are used with the intent to increase durability of the repair but potentially introduce unique complications, offering new challenges in informed surgical consent counseling.


Informed consent is a process that takes place throughout the entire consultation with the patient. A written document often accompanies that process. This paper outlines necessary components of informed surgical consent and the theory behind each component.


We explore elements that should be included in the consent process with regard to expected benefits, alternatives, and material risks that are specific to the use of a mesh/graft-augmented vaginal repair of prolapse. Included is an appendix that may serve as a template for the creation of a surgeon’s own written informed consent document.


Pelvic organ prolapse Mesh Graft Transvaginal mesh Informed consent Pelvic reconstructive surgery 


Conflicts of interest

Dennis Miller, M.D. has received royalties, research grants, and consulting fees from Boston Scientific Corporation and research grants from Ethicon Endosurgery. Alfredo L. Milani, M.D. has received consultancy agreement and speakers bureau fees, research grants, and honoraria for lectures from Ethicon Women’s Health & Urology. Suzette E. Sutherland, M.D. is a consultant, a clinical research PI, and a trainer/speaker of American Medical Systems, Medtronic, Uromedica, and Allergan and a consultant and a trainer/speaker of Uroplasty and Pfizer. Rebecca G. Rogers, M.D. serves as the chair of the Data Safety Monitoring Board for the TRANSFORM trial sponsored by American Medical Systems.


  1. 1.
    Del Carmen MG, Joffe S (2005) Informed consent for medical treatment and research: a review. Oncologist 10:636–641PubMedCrossRefGoogle Scholar
  2. 2.
    ACOG Committee on Ethics (2006) Innovative practice: ethical guidelines. ACOG Committee Opinion Number 352. Obstet Gynecol 108:1589–1595Google Scholar
  3. 3.
    Schenker Y, Meisel A (2011) Informed consent in clinical care: practical considerations in the effort to achieve ethical goals. JAMA 305(11):1130–1131PubMedCrossRefGoogle Scholar
  4. 4.
    Beauchamp TL, Childress JF (2001) Principles of biomedical ethics. Oxford University Press, OxfordGoogle Scholar
  5. 5.
    Berg JW, Applaud PS, Lidz CW et al (2001) Informed consent: legal theory and clinical practice. Oxford University Press, OxfordGoogle Scholar
  6. 6.
    Abed H, Rogers R, Helitzer D, Warner TD (2007) Informed consent in gynecologic surgery. Am J Obstet Gynecol 197(6):674.e1–5Google Scholar
  7. 7.
    Field AD (2004) Informed consent: not just for procedures anymore. Am J Gastroenterol 99:977–980Google Scholar
  8. 8.
    Meisel A, Roth LH, Lidz CW (1997) Toward a model of the legal doctrine of informed consent. Am J Psychiatry 134:285–289Google Scholar
  9. 9.
    American Medical Association (2007) Removing barriers to better, safer care. Health literacy and patient safety: help patients understand. Reducing the risk by designing a safer shame-free health environment. Patient monograph. American Medical Association, ChicagoGoogle Scholar
  10. 10.
    Fink AS, Prochazka AV, Henderson WG et al (2010) Enhancement of surgical informed consent by addition of repeat back: a multicenter, randomized controlled clinical trial. Ann Surg 252(1):27–36PubMedCrossRefGoogle Scholar
  11. 11.
    Heit M, Culligan P, Rosenquist C, Shott S (2002) Is pelvic organ prolapse a cause of pelvic low back pain? Obstet Gynecol 99:23–28PubMedCrossRefGoogle Scholar
  12. 12.
    Slieker-ten Hove MC, Pool-Goudzwaard AL, Eijkemans MJ et al (2009) The prevalence of pelvic organ prolapse symptoms and signs and their relation with bladder and bowel disorders in a general female population. Int Urogynecol J Pelvic Floor Dysfunct 20:1037–1045PubMedCrossRefGoogle Scholar
  13. 13.
    De Boer TA, Kluivers KB, Withagen MI, Milani AL, Vierhout ME (2010) Predictive actors for overactive bladder symptoms after pelvic organ prolapse surgery. Int Urogynecol J Pelvic Floor Dysfunct 21(9):1143–1149CrossRefGoogle Scholar
  14. 14.
    (2008) Interventional Guidance 267. National Institute for Health and Clinical Excellence (NICE), LondonGoogle Scholar
  15. 15.
    Nguyen JN, Burchette RJ (2008) Outcome after anterior vaginal prolapse repair: a randomized controlled trial. Obstet Gynecol 111(4):891–898PubMedCrossRefGoogle Scholar
  16. 16.
    Nieminen K, Hiltunen R, Heiskanen E, Takala T, Niemi K, Merikari M, Heinonen PK (2008) Symptom resolution and sexual function after anterior vaginal wall repair with or without polypropylene mesh. Int Urogynecol J 19:1611–1616CrossRefGoogle Scholar
  17. 17.
    Sivaslioglu AA, Unlubilgin E, Dolen I (2008) A randomized comparison of polypropylene mesh surgery with site-specific surgery in the treatment of cystocoele. Int Urogynecol J 19:467–471CrossRefGoogle Scholar
  18. 18.
    Miller D, Lucente V, Babin E et al (2011) Prospective clinical assessment of the transvaginal mesh technique for treatment of pelvic organ prolapse 5-year results. Female Pelvic Med Reconstr Surg 17:139–143CrossRefGoogle Scholar
  19. 19.
    Caquant F, Collinet P, Debodinance P et al (2008) Safety of Trans Vaginal Mesh procedure: retrospective study of 684 patients. J Obstet Gynaecol Res 34(4):449–456PubMedCrossRefGoogle Scholar
  20. 20.
    Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL (1997) Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 89:501–506PubMedCrossRefGoogle Scholar
  21. 21.
    Maher C, Baessler K, Glazener EJ, Adams HS (2008) Surgical management of pelvic organ prolapse in women: a short version Cochrane review. Neurourol Urodyn 27:3–12PubMedCrossRefGoogle Scholar
  22. 22.
    Hagen S, Stark D, Glazener C, Sinclair L, Ramsay I (2009) A randomized controlled trial of pelvic floor muscle training for stages I and II pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct 20:45–51PubMedGoogle Scholar
  23. 23.
    Dumouulin C, Hay-Smith J (2008) Pelvic floor muscle training versus no treatment for urinary incontinence in women. A Cochrane systematic review. Eur J Phys Rehabil Med 44:47–63Google Scholar
  24. 24.
    Cundiff GW, Amundsen CL, Bent AE et al (2007) The PESSRI study: symptom relief outcomes of a randomized crossover trial of the ring and Gellhorn pessaries. Am J Obstet Gynecol 196:404.e1–404.e8Google Scholar
  25. 25.
    Jefford M, Moore R (2008) Improvement of informed consent and the quality of consent documents. Lancet Oncol 9(5):485–493PubMedCrossRefGoogle Scholar
  26. 26.
    Schenfeld N (2003) Informed consent and its changing nature. Skin Aging 11(07)Google Scholar
  27. 27.
    US Food and Drug Administration (2008) FDA public health notification: serious complications associated with transvaginal placement of surgical mesh in repair of pelvic organ prolapse and stress urinary incontinence. Available at:
  28. 28.
    Abed H, Rahn DD, Lowenstein L, Balk EM, Clemons JL, Rogers RG (2011) Incidence and management of graft erosion, wound granulation, and dyspareunia following vaginal prolapse repair with graft materials: a systematic review. Int Urogynecol J. doi: 10.1007/s00192-011-1384-5
  29. 29.
    Kobashi KC, Govier FE (2003) Management of vaginal erosion of polypropylene mesh slings. J Urol 169(6):2242–2243PubMedCrossRefGoogle Scholar
  30. 30.
    Jacquetin B, Cosson M (2009) Complications of vaginal mesh: our experience. Int Urogynecol J 20:893–896CrossRefGoogle Scholar
  31. 31.
    Araco F, Gravante G, Sorge R, Overton J, De Vita D, Primicerio M, Dati S, Araco P, Piccione E (2009) The influence of BMI, smoking, and age of vaginal erosions after synthetic mesh repair of pelvic organ prolapses. A multicenter study. Acta Obstet et Gynecol 88:772–780CrossRefGoogle Scholar
  32. 32.
    Withagen MI, Viehout ME, Hendricks JC, Kluivers KB, Milani AL (2011) Risk factors for exposure, pain, and dyspareunia after tension-free vaginal mesh procedure. Obstet Gynecol 118:629–636PubMedCrossRefGoogle Scholar
  33. 33.
    Achtari C, Hiscock R, O’Reily BA, Schierlitz L, Dwyer PL (2005) Risk factors for mesh erosion after transvaginal surgery using polypropylene (Atrium) or composite polypropylene/polyglactin 910 (Vypro II) mesh. Int Urogynaecol J Pelvic Dysfunct 16:389–394CrossRefGoogle Scholar
  34. 34.
    Nazemi TM, Kobashi KC (2007) Complications of grafts used in female pelvic floor reconstruction: mesh erosion and extrusion. Indian J Urol 23(2):153–160PubMedCrossRefGoogle Scholar
  35. 35.
    Haylen BT, Freeman RM, Swift SE, Cosson M, Davila GW et al (2011) An international Urogynecological Association (IUGA)/International Continence Society (ICS) joint terminology and classifications of the complications related directly to the insertion of prostheses (meshes, implants, tapes) and grafts in female pelvic floor surgery. Int Urogynecol J 22:3–15PubMedCrossRefGoogle Scholar
  36. 36.
    US Food and Drug Administration (2009) Information on surgical mesh for pelvic organ prolapse and stress urinary incontinence. Available at:
  37. 37.
    Lowenstein L, FitzGerald MP, Kenton K, Dooley Y, Templehof M, Mueller ER, Brubaker L (2008) Patient-selected goals: the fourth dimension in assessment of pelvic floor disorders. Int Urogynecol J 19(1):81–84CrossRefGoogle Scholar

Copyright information

© The International Urogynecological Association 2012

Authors and Affiliations

  • Dennis Miller
    • 1
    Email author
  • Alfredo L. Milani
    • 4
  • Suzette E. Sutherland
    • 2
  • Bonnie Navin
    • 5
  • Rebecca G. Rogers
    • 3
  1. 1.Division of UrogynecologyWheaton Franciscan HealthcareWauwatosaUSA
  2. 2.Metro Urology, Centers for Continence Care and Female UrologyCenter for Pelvic Floor DisordersMinneapolis and St. PaulUSA
  3. 3.Division of UrogynecologyUniversity of New MexicoAlbuquerqueUSA
  4. 4.Department of Obstetrics & GynaecologyReinier de Graaf GroupDelftthe Netherlands
  5. 5.Stearns Weaver Law, LLCFort LauderdaleUSA

Personalised recommendations